Jie Lu’s research while affiliated with University of Pennsylvania and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (51)


Correction for Lu et al., “Latency-Associated Nuclear Antigen of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Upregulates Survivin Expression in KSHV-Associated B-Lymphoma Cells and Contributes to Their Proliferation”
  • Article
  • Publisher preview available

July 2021

·

37 Reads

Jie Lu

·

·

·

[...]

·

View access options





FIG 1 Wild-type EBV infection of Sh-Sy5y cells. Sh-Sy5y cells were grown on 100-mm culture plates. At 60% confluence, in addition to the culture medium, 
FIG 2 Wild-type EBV infection of differentiated human NT-2 neurons. NT-2 neurons were differentiated in six-well plates at a density of 700 to 900 neural clusters per well. In addition to 2 ml of complete culture medium per well, 100 ␮ l (~5.5 ϫ 10 12 viral copies) of concentrated virus was added. The me- 
FIG 3 Wild-type EBV infection of primary human fetal neurons. Primary neurons were plated in six-well plates at 90% confluence and infected in the same manner as NT-2 neurons with the appropriate complete neurobasal culture medium. Fluorescence microscopy was carried out at 2, 4, 6, and 8 dpi to monitor for GFP expression. Microscopy images were captured at ϫ 20 magnification. 
FIG 4 EBV infection of Sh-Sy5y cells produces viral latent and lytic antigen. Sh-Sy5y cells were grown on 100-mm culture plates. At 60% confluence, in addition to the culture medium, 110 ␮ l (~6 ϫ 10 12 viral copies) of concentrated EBV was added to each plate with 5 ␮ l of Polybrene at a 20- ␮ mol/ml concentration. Control cells were supplemented with only medium and Polybrene. (A) Confocal microscopy was carried out at 1, 2, 3, 5, 7, and 9 dpi with primary antibodies to EBNA1, gp350, and DAPI. Secondary antibodies were used as described in Materials and Methods. (B) Cells were harvested at 1, 2, 3, 5, 7, and 9 dpi for WB analyses with primary antibodies to EBNA1, BZLF1, and GAPDH, which were performed and scanned with an Odyssey infrared scanner (LI-COR Biosciences, Lincoln, NE). Microscopy images were captured at ϫ 60 magnification. 
FIG 5 continued 

+3

Gammaherpesvirus Infection of Human Neuronal Cells

December 2015

·

464 Reads

·

56 Citations

Unlabelled: Gammaherpesviruses human herpesvirus 4 (HHV4) and HHV8 are two prominent members of the herpesvirus family associated with a number of human cancers. HHV4, also known as Epstein-Barr virus (EBV), a ubiquitous gammaherpesvirus prevalent in 90 to 95% of the human population, is clinically associated with various neurological diseases such as primary central nervous system lymphoma, multiple sclerosis, Alzheimer's disease, cerebellar ataxia, and encephalitis. However, the possibility that EBV and Kaposi's sarcoma-associated herpesvirus (KSHV) can directly infect neurons has been largely overlooked. This study has, for the first time, characterized EBV infection in neural cell backgrounds by using the Sh-Sy5y neuroblastoma cell line, teratocarcinoma Ntera2 neurons, and primary human fetal neurons. Furthermore, we also demonstrated KSHV infection of neural Sh-Sy5y cells. These neuronal cells were infected with green fluorescent protein-expressing recombinant EBV or KSHV. Microscopy, genetic analysis, immunofluorescence, and Western blot analyses for specific viral antigens supported and validated the infection of these cells by EBV and KSHV and showed that the infection was efficient and productive. Progeny virus produced from infected neuronal cells efficiently infected fresh neuronal cells, as well as peripheral blood mononuclear cells. Furthermore, acyclovir was effective at inhibiting the production of virus from neuronal cells similar to lymphoblastoid cell lines; this suggests active lytic replication in infected neurons in vitro. These studies represent a potentially new in vitro model of EBV- and KSHV-associated neuronal disease development and pathogenesis. Importance: To date, no in vitro study has demonstrated gammaherpesvirus infection of neuronal cells. Moreover, worldwide clinical findings have linked EBV to neuronal pathologies, including multiple sclerosis, primary central nervous system lymphoma, and Alzheimer's disease. In this study, for the first time, we have successfully demonstrated the in vitro infection of Sh-Sy5y and Ntera2 cells, as well as human primary neurons. We have also determined that the infection is predominately lytic. Additionally, we also report infection of neuronal cells by KSHV in vitro similar to that by EBV. These findings may open new avenues of consideration related to neuronal pathologies and infection with these viruses. Furthermore, their contribution to chronic infection linked to neuronal disease will provide new clues to potential new therapies.


Dissecting the contribution of EBNA3C domains important for EBV- induced B-cell growth and proliferation

September 2015

·

145 Reads

·

8 Citations

Oncotarget

Epstein-Barr virus (EBV) is an oncogenic gammaherpes virus which is linked to pathogenesis of several human lymphatic malignancies. The EBV essential latent antigen EBNA3C is critical for efficient conversion of primary human B-lymphocytes to lymphoblastic cell lines and for continued LCL growth. EBNA3C, an EBV latent antigen with oncogenic potential can bind and regulate the functions of a wide range of cellular transcription factors. In our current reverse genetics study, we deleted the full length EBNA3C, and independently the RBP-Jκ and Nm23-H1 binding sites within EBNA3C using BACmid recombinant engineering methodology. Our experiments demonstrated that deletion of the EBV EBNA3C open reading frame (ORF) and more specifically the residues 621–675 which binds Nm23H1 and SUMO-1 showed a significant reduction in the ability of the cells to proliferate. Furthermore, they exhibited lower infectivity of human peripheral blood mononuclear cells (PBMCs). We also showed that recombinant EBV with deletions of the EBNA3C ORF, as well as a recombinant with residues 621– 675 within EBNA3C ORF deleted had diminished abilities to activate CD40. Our study also revealed that the full length (1–992) and 621–675 aa deletions of EBNA3C when compared to wild type EBV infected PBMCs had differential expression patterns for the phosphorylation of MAP kinases specifically p38, JNK and ERK. Regulation of β-catenin also differed among wild type and EBNA3C deleted mutants. These temporal differences in signaling activities of these recombinant viruses in PBMCs is likely important in defining their functional importance in EBV-mediated B-cell transformation.




Kaposi's Sarcoma-Associated Herpesvirus Genome Programming during the Early Stages of Primary Infection of Peripheral Blood Mononuclear Cells

December 2014

·

168 Reads

·

25 Citations

Unlabelled: The early period of Kaposi's sarcoma-associated herpesvirus (KSHV) infection involves the dynamic expression of viral genes, which are temporally and epigenetically regulated. KSHV can effectively infect and persist in endothelial as well as human B cells with different gene expression patterns. To understand the temporal epigenetic changes which occur when KSHV infects the lymphocytic compartment, we infected human peripheral blood mononuclear cells (PBMCs) and comprehensively analyzed the changes which occurred at the binding sites of virally encoded lytic as well as latent proteins along with epigenetic modifications across the KSHV genome during early primary infection. Using chromatin immunoprecipitation (ChIP) assays, we showed that the KSHV genome acquires a uniquely distinct histone modification pattern of methylation (H3K4me3, H3K9me3, and H3K27me3) and acetylation (H3Ac) during de novo infection of human PBMCs. This pattern showed that the epigenetic changes were temporally controlled. The binding profiles of KSHV latent protein LANA and the immediate early proteins RTA and K8 showed specific patterns at different times postinfection, which reflects the gene expression program. Further analysis demonstrated that KSHV can concurrently express lytic and latent genes which were associated with histone modifications at these specific regions on the viral genome. We identified three KSHV genes, K3, ORF49, and ORF64, which exhibited different profiles of histone modifications during the early stages of PBMC infection. These studies established a distinct pattern of epigenetic modification which correlates with viral gene expression temporally regulated during the first 7 days of PBMC infection and provides clues to the regulatory program required for successful infection by KSHV of human PBMCs. Importance: Kaposi's sarcoma-associated herpesvirus (KSHV) has been documented as one of the major contributors to morbidity and mortality in AIDS patients during the AIDS pandemic. During its life cycle, KSHV undergoes latent and lytic replication. Typically, KSHV maintains a stringent preference for latent infection in the infected B cells. However, 1 to 5% of infected cells undergo spontaneous lytic reactivation. KSHV lytic replication and infection of new cells are likely to be critical for maintaining the population of infected cells which drive virus-associated pathogenesis. Here, we explored the temporal changes of crucial histone marks on the KSHV genome during early infection of human primary peripheral blood mononuclear cells (PBMCs), which are a physiologically relevant system for monitoring primary infection. These results showed that KSHV possessed a distinct pattern of epigenetic marks during early infection of PBMCs. Further, KSHV concurrently expressed lytic and latent genes during this early period. These results now provide new evidence which contributes to understanding the molecular mechanism that regulates viral gene expression during early infection.


Citations (26)


... 感染的细胞被宿主的 NK 细胞及 T 细胞识别并清除,从而防止 EBV 诱导 B 细胞及上皮细胞 癌变 [22] 。当机体免疫细胞对感染 EBV 的细胞清除能力减弱,在化学物刺激及外界环境因素 影响下,EBV 可发生异常的裂解复制,病毒子代可感染上皮细胞、NK 细胞、T 细胞、平滑 肌细胞、滤泡树突状细胞甚至神经细胞,导致相关感染性疾病发生 [23][24][25] 。 2 EBV 感染相关疾病的流行病学负担及流行特征 据估计 EBV 感染每年导致超过 20 万例恶性肿瘤的发生,占所有癌症的 1.8% [1,26,27] 。同 时 EBV 感染也与多种良性疾病和自身免疫疾病密切相关,如传染性单核细胞增多症 (Infectious Mononucleosis,IM) [28] 、多发性硬化症(Multiple Sclerosis,MS) [29] 和系统性 红斑狼疮(Systemic Lupus Erythematosus,SLE) [30,31] 。 在儿童期 EBV 的原发感染多无症状,从感染到发病的潜伏期长达 6 周 [32] 。如果原发感 染发生在青少年或青年中发生 EBV 原发感染时,呈现为传染性单核细胞增多症(Infectious ...

Reference:

EB病毒流行病学与全球疾病负担
Gammaherpesvirus Infection of Human Neuronal Cells

... EBNA-3C is another EBV protein that exhibits anti-apoptotic activity. The expression of EBNA-3C was observed in immunoblastic lymphomas [124] and found to be necessary for in vitro transformation of primary B lymphocytes into LCLs [125]. ...

Dissecting the contribution of EBNA3C domains important for EBV- induced B-cell growth and proliferation

Oncotarget

... KSHV, also known as human herpesvirus 8, belongs to the gamma-herpesvirus family, which is linked to primary effusion lymphoma (PEL), multicentric Castleman's disease (MCD), and Kaposi's sarcoma (KS). [55][56][57] One of the crucial latent antigens encoded by KSHV, the latencyassociated nuclear antigen (LANA), expressed in virusinfected tumor cells that cause KSHV-associated cancers. 58 In KSHV-associated human cancers, LANA can destabilize the p53 tumor suppressor's functions and increase the expression of the cellular oncogene AURKA. ...

Kaposi's Sarcoma-Associated Herpesvirus Genome Programming during the Early Stages of Primary Infection of Peripheral Blood Mononuclear Cells

... The structures of the compounds under investigation in our study are presented in Figure 1. Two of the compounds, cellocidin (NSC#65381) and bruceantin (NSC#165563), have already been demonstrated to be effective against EBV, although a detailed mechanism remains to be studied (Dzeng et al., 2015). Briefly, cellocidin can induce necrotic cell death by manipulating the NF-jB, and c-Myc-regulated apoptosis pathway in EBV infected B cells (Dzeng et al., 2015). ...

Small Molecule Growth Inhibitors of Human Oncogenic Gammaherpesvirus Infected B-Cells
  • Citing Article
  • September 2014

Molecular Oncology

... EBNA3C also increases cyclin D2 stability by affecting the proteasomal degradation of Bcl6 [63]. Additionally, EBNA3C promotes cell proliferation by stabilizing Pim-1, inhibiting its proteasomal degradation, and ultimately leading to the downregulation of the cell cycle inhibitor p21/WAF1 [64]. Furthermore, EBNA3C is implicated in DNA instability and obstructs DNA damage repair pathways by downregulating transcription and promoting the proteasomal degradation of H2AX, an essential player in DNA stability and damage repair [65]. ...

EBNA3C Augments Pim-1 Mediated Phosphorylation and Degradation of p21 to Promote B-Cell Proliferation

... Further, LANA recruits and upregulates the EC(5)S ubiquitin complex, leading to increased p53 proteasomal degradation. This also leads to the dysregulation of Bub1 activity, causing downstream dysregulation of chromosome replication and aneuploidy [76,77]. Moreover, LANA increases Aurora A expression, and Aurora A subsequently enhances the p53-LANA binding affinity [78]. ...

Kaposi's Sarcoma-Associated Herpesvirus-Encoded LANA Can Induce Chromosomal Instability through Targeted Degradation of the Mitotic Checkpoint Kinase Bub1

... This detrimental role of TRIM28 in gene transcription has significant consequences for viral transcription and replication. TRIM28 has previously been shown to repress viral transcription for several herpesviruses including the KSHV, HCMV, and Epstein-Barr virus (EBV) [26,31,32]. TRIM28 has also been shown to inhibit HIV-1 replication by binding the acetylated HIV-1 integrase and preventing the integration of pro-viral DNA [33] and to mediate the transcription suppression of the HIV-1 LTR promoter [34,35]. ...

Inhibition of KAP1 enhances hypoxia-induced KSHV reactivation through RBP-Jκ

... Small sample size is a limitation of the present study [14]. Anti-apoptotic properties of KSHV infected primary cells was observed previously [15,16]. The presence of latent virus in KSHV-associated cancers provides a potential target for therapy. ...

Kaposi's Sarcoma-Associated Herpesvirus-Encoded LANA Contributes to Viral Latent Replication by Activating Phosphorylation of Survivin

... Additionally, EBNA3C promotes cell proliferation by stabilizing Pim-1, inhibiting its proteasomal degradation, and ultimately leading to the downregulation of the cell cycle inhibitor p21/WAF1 [64]. Furthermore, EBNA3C is implicated in DNA instability and obstructs DNA damage repair pathways by downregulating transcription and promoting the proteasomal degradation of H2AX, an essential player in DNA stability and damage repair [65]. Both EBNA3C and EBNA3A have been shown to interact with the USP46/USP12 DUB complex, leading to EBV-associated oncogenesis [66]. ...

Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression

... LANA interacts with multiple chromatin binding proteins that have been implicated in enhancer regulation, including BRD2, BRD4, EZH2, IRF4, and CHD4. 51,53,[63][64][65][66][67][68][69] To test whether LANA occupancy overlaps with their binding, we generated CUT&RUN data in TREx-BCBL1-RTA cells for each factor, with the exception of CHD4, in which we analyzed published chromatin immunoprecipitation sequencing (ChIP-seq) data generated in TREx-BCBL1-RTA cells. 51 Aggregation of the EZH2 and BRD2 CUT&RUN signal revealed minimal overlap. ...

IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation